ghk-cu peptide oral bioavailability Repost from @skincareanarchy • Copper peptides are one of the most misunderstood ghk cu oral bioavailability study

Fuhrman B, Volkova N, Aviram M

Clinical trials would need to assess both hemodynamic parameters and clinical outcomes including walking distance, pain scores, and amputation rates to establish therapeutic benefit

Giannoulis MG, Sonksen PH, Umpleby M, et al

Zh Vyssh Nerv Deiat Im I P Pavlova 1998;48:153-160

Therapeutically, tachykinin receptor antagonists have been explored in asthma, with some reports suggesting beneficial effects (reviewed here [85])

Signs you should hold your current dose include nausea lasting more than three days after injection, vomiting more than once per week, inability to maintain adequate hydration, or significant disruption to daily activities